Currently, the importance of PI3K pathways in the development of Tregs is under intense investigation40, and dramatic anti-tumor effects have been seen in trials using PI3Kδ inhibition in patients with chronic lymphocytic leukemia41. The gene discussed is PIK3CD; the disease is neoplasm.